For the Inventor, By the Inventor

Enter assignee name

Burnaby, Canada

Qu Biologics Inc.

USPTO Granted Patents = 13

CIPO Patents = 11

EPO Patents = 5

Forward Citations = 73

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Harold David Gunn (13 out of 18 patents)

Salim Dhanji (4 out of 6 patents)

David W Mullins (4 out of 5 patents)

4. Shirin Kalyan (2 out of 2 patents)

5. Mark Bazett (2 out of 2 patents)

6. Brett Anthony Premack (2 out of 9 patents)

7. Michael Tak Huai Chow (2 out of 2 patents)

8. Momir Bosiljcic (1 out of 1 patent)

9. Monan Angela Zhang (1 out of 1 patent)

10. Marcel Thalen (1 out of 1 patent)

11. Dermot McGovern (1 out of 8 patents)

12. Boyko Traychev Kabakchiev (1 out of 1 patent)

13. Ho Pan Sham (1 out of 1 patent)

14. Gunn Harold D D (0 patent)

13 patents: Sort by Forward Citations

1. 12491153 - Innate targeting of adoptive cellular therapies (2025-12-09),

2. 11819543 - Anti-microbial immunomodulation (2023-11-21),

3. 11226340 - Therapeutically triggering an innate immune response in a target tissue (2022-01-18),

4. 10251946 - Anti-microbial immunomodulation (2019-04-09),

5. 10130692 - Immunogenic anti-inflammatory compositions (2018-11-20),

6. 10086066 - Tissue targeted antigenic activation of the immune response to treat cancers (2018-10-02),

7. 9775896 - Tissue targeted antigenic activation of the immune response to treat cancers (2017-10-03),

8. 9320788 - Tissue targeted antigenic activation of the immune response to treat cancers (2016-04-26),

9. 9320787 - Tissue targeted antigenic activation of the immune response to treat cancers (2016-04-26),

10. 9107864 - Tissue targeted antigenic activation of the immune response to treat cancers (2015-08-18),

11. 8980279 - Personalized site-specific immunomodulation (2015-03-17),

12. 8501198 - Tissue targeted antigenic activation of the immune response to treat cancers (2013-08-06),

13. 8034359 - Tissue targeted antigenic activation of the immune response to cancers (2011-10-11),

Qu Biologics is a Vancouver-based biopharmaceutical company focused on the development of immunotherapies to treat chronic inflammatory diseases. Their innovative platform technology, Site Specific Immunomodulators (SSIs), leverages the body's natural immune response to restore immune function and promote tissue healing. Qu Biologics is dedicated to transforming the lives of patients suffering from conditions like Crohn's disease, ulcerative colitis, and lung cancer.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

13 Patents

#29 in Burnaby

#1,107 in Canada

#43,615 in the World

Burnaby, Canada

Qu Biologics Inc.

Forward Citations = 73

14 inventors:

Harold David Gunn (13 out of 18 patents)

Salim Dhanji (4 out of 6 patents)

David W Mullins (4 out of 5 patents)

4. Shirin Kalyan (2 out of 2 patents)

5. Mark Bazett (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…